1. Home
  2. CSBR vs NVX Comparison

CSBR vs NVX Comparison

Compare CSBR & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$5.07

Market Cap

81.0M

Sector

Health Care

ML Signal

HOLD

Logo NOVONIX Limited American Depository Shares

NVX

NOVONIX Limited American Depository Shares

HOLD

Current Price

$0.44

Market Cap

95.9M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
NVX
Founded
1985
2012
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
81.0M
95.9M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
CSBR
NVX
Price
$5.07
$0.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7K
168.0K
Earning Date
03-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,900,000.00
N/A
Revenue This Year
$4.84
$3,904.19
Revenue Next Year
$11.51
$91.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.88
$0.37
52 Week High
$8.74
$3.86

Technical Indicators

Market Signals
Indicator
CSBR
NVX
Relative Strength Index (RSI) 35.96 48.89
Support Level N/A $0.41
Resistance Level $6.31 $0.49
Average True Range (ATR) 0.34 0.03
MACD -0.04 0.01
Stochastic Oscillator 7.50 62.42

Price Performance

Historical Comparison
CSBR
NVX

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd is a battery technology company developing and scaling materials and equipment critical to the lithium-ion battery supply chain. The company has three operating segments: Battery Materials: It develops and manufactures battery anode materials, ii) Battery Technology: It develops and manufactures battery cell testing equipment, performs consulting services and carries out research and development in battery development, and Graphite Exploration: It manages the maintenance and future development of Mount Dromedary natural graphite deposit. The majority of the company's revenue is derived from the Battery Technology segment. Geographically, the maximum revenue is derived from North America, followed by Asia, and Europe.

Share on Social Networks: